Compare Nexgen Energy Ltd. Common Shares (NXE) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nexgen Energy Ltd. Common Shares vs Relay Therapeutics Inc. Common Stock — how do they compare? Nexgen Energy Ltd. Common Shares trades at $8.82 (market cap $5.80B), while Relay Therapeutics Inc. Common Stock trades at $18.03 (market cap $3.82B). The key difference: Nexgen Energy Ltd. Common Shares is the larger of the two by market cap, and Relay Therapeutics Inc. Common Stock is trading nearer its 52-week high, Nexgen Energy Ltd. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nexgen Energy Ltd. Common Shares for 1 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| NXE | RLAY | |
|---|---|---|
Market Cap | $5.80B | $3.82B |
Volume | 6,795,738 | 4,332,079 |
Sector | Energy | Health |
52-Week High | $13.92 | $20.75 |
52-Week Low | $7.56 | $6.03 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $5.55B | $2.93B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Nexgen Energy Ltd. Common Shares
NexGen Energy develops uranium projects in Canada. Its main asset is the Rook I Project in Saskatchewan, which includes the Arrow uranium deposit.
Read more on NXE →About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →
